Qiagen expands offerings via China's BGI; Uni-Bio files for osteoporosis drug nod in China;

> Qiagen ($QGEN) expands offerings to China's BGI by providing its Ingenuity Variant Analysis for all customers of BGI's sequencing services. Release

> Hong Kong-listed Golden Meditech Holdings will pay $160 million to buy 7% senior convertible notes due 2017 issued by China Cord Blood Corp. Release (PDF)

> Uni-Bio files for China approval of novel osteoporosis drug. Release (PDF)

> Echo Therapeutics ($ECTE) said its strategic partner, Medical Technologies Innovation Asia, met with the China FDA to define its strategy and clinical pathway for regulatory approval. Release